Serum Institute of India will manufacture a chikungunya vaccine for the Indian market and a few other Asian countries under a ...

Check the time stamp on this data. Updated AI-Generated Signals for Sprott Inc. (SII) available here: SII.

Denmark: Bavarian Nordic A/S has announced a license and manufacturing agreement for its MVA-BN mpox vaccine with Serum ...

As Bavarian Nordic works to increase global access to its mpox vaccine, the company has inked a manufacturing licensing pact ...

India reported the first case of mpox disease caused by the “clade 1b” strain that prompted WHO to declare the infection a ...

Bavarian Nordic will transfer the technology of the current manufacturing process to SII to enable supply for the Indian ...

France: Valneva SE, a specialty vaccine company, and Serum Institute of India (SII), the world's largest manufacturer of ...

The legacy lives on under the stewardship of his son, Adar Poonawalla, CEO of the company. Meanwhile, the daughter-in-law, ...

Saint-Herblain (France), Pune, (India), December 19, 2024 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum Institute of India (SII), the world’s largest manufacturer ...

Bavarian Nordic partners with Serum Institute of India for MVA-BN vaccine manufacturing, expanding global supply during mpox ...

The funding round was led by Serum Institute of India (SII) with participation from the European Innovation Council (EIC) Fund and other investors. Proceeds will support key activities, including ...

Valneva will supply its chikungunya vaccine drug substance to SII, which will complete manufacturing and be responsible for ...